Cargando…
PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429346/ http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76 |
_version_ | 1784779411900334080 |
---|---|
author | Hariharan, L. Champion-Homfray, M. Hassan, E. |
author_facet | Hariharan, L. Champion-Homfray, M. Hassan, E. |
author_sort | Hariharan, L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94293462022-08-31 PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY Hariharan, L. Champion-Homfray, M. Hassan, E. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429346/ http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Hariharan, L. Champion-Homfray, M. Hassan, E. PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title | PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title_full | PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title_fullStr | PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title_full_unstemmed | PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title_short | PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY |
title_sort | pb2267: covid-19 outcomes on haematology patients who received rituximab: single centre study |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429346/ http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76 |
work_keys_str_mv | AT hariharanl pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy AT championhomfraym pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy AT hassane pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy |